from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0817c/-

LFCtreatmentdescriptionclass of inhibitor

0.743

Amikacinug/mL Amikacintranslation

0.961

Cap5-10ug/mL Capreomycintranslation

1.160

Rox10-50 ug/mL Roxithromycintranslation

-0.582

SM2-5 ug/mL Streptomycintranslation

2.443

Tet5-10 ug/mL Tetracyclinetranslation

0.781

Rif0.2-5ug/mL Rifampicintranscription

0.474

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.508

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.325

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.325

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.835

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.269

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.278

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.189

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.088

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.213

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.115

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.506

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.458

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.448

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.044

KCN5-20 ug/mL Potassium cyaniderespiration

-0.420

NaN30.2-2 mM Sodium aziderespiration

0.125

Nigericin50 uM Nigericinrespiration

0.359

TRC10-150 ug/mL Triclosanrespiration

0.697

TRZ10-25 ug/mL Thioridazinerespiration

-0.208

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.442

menadione6-10 ug/mL Menadionerespiration

-0.418

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.006

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.233

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.195

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.598

NRP_1Non-replicating persistence stage 1dosRassociated

-0.521

Amp0.2mg/mL AmpicillincellWall

-0.223

Cephalexin20-100 ug/mL CephalexincellWall

1.290

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.495

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.195

EMB10-20 ug/mL EthambutolcellWall

-0.425

Eta12-40 ug/mL EthionamidecellWall

-0.857

INH0.2-0.4 ug/mL IsoniazidcellWall

0.488

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.083

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.297

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.649

BZA0.12 mg/mL BenzamidearomaticAmides

0.600

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.002

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.009

H2O24 mM hydrogen peroxideDNAdamaging

0.342

Levo10 ug/mL LevofloxacinDNAdamaging

-0.201

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.885

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.369

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.097

UVUV-irradiationDNAdamaging

-0.155

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.138

Antimycin12.5-50 ug/mL Antimycin A?

0.395

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.843

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.007

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.953

PA8240.2-2 ug/mL PA-824?

-0.671

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.101

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.081

Verapamil50 uM Verapamil?

1.075

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.362

methoxatin10-20 ug/mL Methoxatin?